Chow CK, Ramasundarahettige C, Hu W, et al
Clinical Efficacy Evidence for Compounded GLP-1 Therapy Published outcomes from compounded semaglutide programs show weight loss and metabolic improvements consistent with brand-name formulations
Supporting Safe and Scalable Weight Loss Programs As clinics expand their GLP-1 offerings, maintaining consistent standards becomes increasingly important
In addition to the physical changes, I experienced a noticeable improvement in energy, recovery, and general well-being
This is reflected in our pooled meta-analysis estimate, which shows no statistically significant increase in aspiration risk (OR 1.23
American Journal of Psychiatry, 156(1), 145-147